Jin Piao

Assistant Professor

University of Southern California

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jin Piao is an Assistant Professor at the University of Southern California, USA. His research primarily focuses on pediatric oncology, particularly the treatment of tumors with specific genomic alterations and the challenges associated with rare tumors. Recent articles include studies on novel therapies for children and young adults undergoing treatment for various tumor types, emphasizing the importance of precision medicine in cancer care.

Articles (7)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Douglas Hawkins

Professor

University of Washington

UNITED STATES

View details

Emily Christison-Lagay

Yale University

UNITED STATES

View details

Sinchita Roy‐Chowdhuri

UNITED STATES

View details

DOLORES LOPEZ-TERRADA

Division Chief

Baylor College of Medicine

UNITED STATES

View details

Olive Eckstein

Baylor College of Medicine

UNITED STATES

View details

Stephen Dunn

Chief

Nemours Children's Health System

UNITED STATES

View details

Carl E. Allen

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jin Piao

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D

Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial

Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee

Collaborators (7)

Douglas Hawkins

Emily Christison-Lagay

Sinchita Roy‐Chowdhuri

DOLORES LOPEZ-TERRADA

Olive Eckstein

Stephen Dunn

Carl E. Allen

Make your next move.